Letters Outpatient parenteral antimicrobial therapy

Consider bronchiectasis too

BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f2495 (Published 24 April 2013) Cite this as: BMJ 2013;346:f2495
  1. Andrew R Medford, respiratory physician
  1. 1North Bristol Lung Centre, Southmead Hospital, Bristol BS10 5NB, UK
  1. andrewmedford{at}hotmail.com

In addition to the conditions listed by Chapman,1 outpatient parenteral antimicrobial therapy (OPAT) has potential application for infective exacerbations of non-cystic fibrosis bronchiectasis, where effective oral antimicrobials are often lacking. A feasibility study …

View Full Text

Log in

Log in through your institution


* For online subscription